Erika is the CEO and co-founder of Sanguina, a company that spun out of Georgia Tech and Emory University in 2014. Sanguina is focused on development and launch of home use wellness tools, including AnemoCheck, a color-based disposable screening tool for anemia, which won 2nd place in the Georgia Tech InVenture Prize competition in 2013. Since winning, Sanguina has raised over $1.5M in non-dilutive grant funding for continued development and commercialization of several technologies. In 2017, the company received FDA clearance on AnemoCheck for clinical use, and the company is currently pursuing over-the-counter clearance.Sanguina aims to market direct to consumer offering access to “your health at your fingertips”. Erika graduated from Georgia Tech with her degree in biomedical engineering in 2012. Since graduating, she has garnered both technical and entrepreneurial skills through hands on execution of all preclinical and clinical assessments, regulatory studies and strategies, quality management systems development, company operations, funding management, and team expansion. Erika holds one method patent for her AnemoCheck technology, and has several others pending. Erika also functions as the Director of Operations for the newly NIH-funded Atlanta Center for Microsystems-Engineered Point-of-Care Technologies (ACME-POCT). There she assists teams who have developed or are developing microsystems-based POC technologies to define their clinical needs, conduct clinical validation, and refine their technology with the objective of accelerating the path to translation and clinical adoption and directly addressing the barriers thereof.